Law360, New York (October 29, 2009) -- A magistrate judge in a contract and trade secrets suit brought by Brigham Young University and a professor who claims he had a key role in discovering an enzyme that led to the development of Bextra and Celebrex has sanctioned the drugs' maker, a move the judge said she hoped would entice Pfizer Inc. to comply with its discovery obligations.
On Wednesday, Magistrate Judge Brooke Wells of the U.S. District Court for the District of Utah partially granted BYU's motion for sanctions against Pfizer and ordered the drugmaker to shell...
